The global transplant market will reach $29bn in 2019 and is estimated to grow at a CAGR of 9.9% from 2018- 2029. Visiongain estimated that Germany will hold 7.3% of the global transplant market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 184-page report you will receive 82 tables and 55 figures– all unavailable elsewhere.
The 184-page report provides clear detailed insight into the transplant market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Transplant Market from 2019-2029
• Forecast of the Global Transplant market by Product:
• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions
• Forecast of the Global Transplant market by Application:
• Tissue Transplant: Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues
• Organ Transplant: Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant
• Forecast of the Global Transplant market by End-user:
• Hospitals
• Transplant Centers
• Others
• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: US, Canada
• EU: Germany, France, United Kingdom, Italy, Spain and rest of EU
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa and rest of ROW
• Our study discusses the selected leading companies that are the major players in the transplant market:
• AbbVie, Inc.
• Arthrex, Inc.
• Medtronic
• Novartis AG
• Stryker
• Teva Pharmaceuticals
• Veloxis Pharmaceuticals
• Zimmer Biomet
• This study discusses the competitive landscape, including factors that drive and restrain the transplant market
• This report also provides the number organ transplant procedures from 2012-2017 in selected countries:
• The US
• Canada
• Germany
• UK
• France
• Italy
• Spain
• Japan
• China
• Brazil
• Mexico
• South Africa
• Russia
Visiongain’s study is intended for anyone requiring commercial analyses for the transplant market. You find data, trends and predictions.
Buy our report today Global Transplant Market Analysis : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Why You Should Read This Report
1.2 How This Report Delivers
1.3 Key Questions Answered by This Analytical Report Include:
1.4 Who is This Report for?
1.5 Methodology
1.5.1 Primary Research
1.5.2 Secondary Research
1.5.3 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2. Introduction to Transplant
2.1 What is Transplant?
2.2 What is Transplantation?
2.3 What is Organ Rejection?
2.4 History of Organ and Tissue Transplant
2.5 Types of Transplant
2.5.1 Autotransplantation
2.5.2 Allotransplantation
2.5.3 . Xenotransplantation
2.6 Risks Associated with Transplantation
2.7 Number of Organ transplant Procedures in Major Countries
2.7.1 U.S.
2.7.2 Canada
2.7.3 Germany
2.7.4 UK
2.7.5 France
2.7.6 Italy
2.7.7 Spain
2.7.8 Japan
2.7.9 China
2.7.10 Brazil
2.7.11 Mexico
2.7.12 South Africa
2.7.13 Russia
2.8 Humanistic and Economic Burden
2.8.1 Morbidity and Mortality
2.8.2 Economic Impact
3. Global Transplant Market Size and Forecast, 2019-2029
4. Global Transplant Market Size and Forecast by Product, 2019-2029
4.1 Tissue Products
4.2 Immunosuppressive Drugs
4.3 Preservation Solutions
5. Global Transplant Market Size and Forecast by Application, 2019-2029
5.1 Tissue Transplant
5.1.1 Heart Valve Replacement
5.1.2 Vascular Grafts Replacement
5.1.3 Bone Grafts Transplantation
5.1.4 Cornea Transplantation
5.1.5 Skin Grafts Transplantation
5.1.6 Bone Marrow Transplantation
5.1.7 Other Tissues Transplant
5.2 Organ transplant
5.2.1 Kidney Transplant
5.2.2 Liver Transplant
5.2.3 Heart Transplant
5.2.4 Lung Transplant
5.2.5 Pancreas Transplant
5.2.6 Other Organ Transplant
6. Global Transplant Market Size and Forecast by End-User, 2019-2029
6.1 Hospitals
6.2 Transplant Centers
6.3 Others
7. Transplant Market Landscape
7.1 Market Drivers
7.1.1 Increased Incidence of Organ Failure
7.1.2 Advances in Technology
7.1.3 Initiatives by Government and NGO’s to Create Awareness for Organ Donation
7.1.4 Increased M&A and Strategic Collaboration
7.1.5 Increased Healthcare Expenditure
7.1.6 Developed Tissue banks
7.1.7 Innovation of 3D Bioprinting
7.2 Market Growth Inhibitors
7.2.1 Transplant Rejection
7.2.2 Intense Competition among Vendors
7.2.3 Shortage of Organ Donors
7.2.4 Ethical and Cultural Issues
8. Global Transplant Market Size and Forecast by Region, 2019-2029
8.1 North America Transplant Market Forecast 2019 - 2029
8.1.1 U.S. Transplant Market Forecast 2019 - 2029
8.1.2 Canada Transplant Market Forecast 2019 - 2029
8.2 Europe Transplant Market Forecast 2019 - 2029
8.2.1 Germany Transplant Market Forecast 2019 - 2029
8.2.2 UK Transplant Market Forecast 2019 - 2029
8.2.3 France Transplant Market Forecast 2019 - 2029
8.2.4 Italy Transplant Market Forecast 2019 - 2029
8.2.5 Spain Transplant Market Forecast 2019 - 2029
8.2.6 Rest of Europe Transplant Market Forecast 2019 - 2029
8.3 Asia-Pacific Transplant Market Forecast 2019 - 2029
8.3.1 Japan Transplant Market Forecast 2019 - 2029
8.3.2 China Transplant Market Forecast 2019 - 2029
8.3.3 India Transplant Market Forecast 2019 - 2029
8.3.4 Rest of Asia-Pacific Transplant Market Forecast 2019 - 2029
8.4 RoW Transplant Market Forecast 2019 - 2029
8.4.1 Brazil Transplant Market Forecast 2019 - 2029
8.4.2 Mexico Transplant Market Forecast 2019 - 2029
8.4.3 Russia Transplant Market Forecast 2019 - 2029
8.4.4 South Africa Transplant Market Forecast 2019 - 2029
8.4.5 Rest of RoW Market Forecast 2019 – 2029
9. Leading Companies in the Global Transplant Market
9.1 Zimmer Biomet
9.1.1 Overview
9.1.2 Leading Products
9.1.3 Recent Developments
9.1.4 SWOT Analysis
9.2 AbbVie Inc.
9.2.1 Overview
9.2.2 Leading Products
9.2.3 Strategic Planning
9.2.4 SWOT Analysis
9.3 Teva Pharmaceuticals
9.3.1 Overview
9.3.2 Leading Products
9.3.3 Recent Developments
9.3.4 SWOT Analysis
9.4 Novartis AG
9.4.1 Overview
9.4.2 Leading Products
9.4.3 Recent Developments
9.4.4 SWOT Analysis
9.5 Medtronic
9.5.1 Overview
9.5.2 Leading Products
9.5.3 Recent Developments
9.5.4 SWOT Analysis
9.6 Arthrex
9.6.1 Overview
9.6.2 Leading Products
9.6.3 Recent Developments
9.6.4 SWOT Analysis
9.7 Stryker Corporation
9.7.1 Overview
9.7.2 Leading Products
9.7.3 Recent Developments
9.7.4 SWOT Analysis
9.8 Veloxis Pharmaceuticals
9.8.1 Overview
9.8.2 Leading Products
9.8.3 Recent Developments
9.8.4 SWOT Analysis
10. Other Prominent Companies
11. Conclusion
Appendices
Associated Reports
Report Sales Order Form
About Visiongain
Report Evaluation Form
List of Tables
Table 2.1. Organ Transplant Procedure Average Cost
Table 3.1. Global Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 4.1 Global Tissue Products Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 4.2 Global Immunosuppressive Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 4.3 Global Preservation Solutions Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.1. Global Tissue Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.2 Global Heart Valve Replacement Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.3 Global Vascular Grafts Replacement Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.4 Global Bone Grafts Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.5 Global Cornea Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.6 Global Skin Grafts Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.7 Global Bone Marrow Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.8 Global Other Tissue Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.9 Global Organ Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.10 Global Kidney Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.11 Global Liver Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.12 Global Heart Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.13 Global Lung Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.14 Global Pancreas Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.15 Global Other Organ Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Figure 6.1 Global Transplant Market Segmentation by End-User
Table 6.1. Global Hospital Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 6.2 Global Transplant Centers Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 6.3 Global Others End Use Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.1 North America Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.2 North America Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.3 North America Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.4 North America Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.5 North America Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.6 North America Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.7 U.S. Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.8 Canada Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.9 Europe Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.10 Europe Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.11 Europe Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.12 Europe Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.13 Europe Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.14 Europe Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.15 Germany Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.16 UK Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.17 France Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.18 Italy Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.19 Spain Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.20 Rest of Europe Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.21 Asia-Pacific Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.22 Asia-Pacific Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.23 Asia-Pacific Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.24 Asia-Pacific Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.25 Asia-Pacific Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.26 Asia-Pacific Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.27 Japan Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.28 China Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.29 India Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.30 Rest of Asia-Pacific Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.31 RoW Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.32 RoW Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.33 RoW Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.34 RoW Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.35 RoW Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.36 RoW Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.37 Brazil Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.38 Mexico Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.39 Russia Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.40 South Africa Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.41 Rest of RoW Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 9.1 Zimmer Biomet: Overview
Table 9.2 Zimmer Biomet: Leading Products
Table 9.3 AbbVie Inc.: Overview
Table 9.4 AbbVie Inc.: Leading Products
Table 9.5 Teva Pharmaceuticals: Overview
Table 9.6 Teva Pharmaceuticals: Leading Products
Table 9.7 Novartis AG: Overview 2017
Table 9.8 Novartis AG: Leading Products
Table 9.9: Medtronic: Overview
Table 9.10 Medtronic: Leading Products
Table 9.11 Arthrex: Overview
Table 9.12 Arthrex: Leading Products
Table 9.13 Stryker Corporation: Overview
Table 9.14 Stryker Corporation: Leading Products
Table 9.15 Veloxis Pharmaceuticals: Overview
Table 9.16 Veloxis Pharmaceuticals: Leading Products
Table 10.1 List of Other Prominent Companies in the Transplant Market
List of Figures
Figure 2.1 Types of Transplant
Figure 2.2 Registered diabetes people in England in 2016 by gender
Figure 2.3 Number of Transplant Procedures (2012-2017)
Figure 2.4 Number of Transplant Procedures (2012-2017)
Figure 2.5 Number of Transplant Procedures (2012-2017)
Figure 2.6 Number of Transplant Procedures (2012-2017)
Figure 2.7 Number of Transplant Procedures (2012-2017)
Figure 2.8 Number of Transplant Procedures (2012-2017)
Figure 2.9 Number of Transplant Procedures (2012-2017)
Figure 2.10 Number of Transplant Procedures (2012-2017)
Figure 2.11 Number of Transplant Procedures (2015-2016)
Figure 2.12 Number of Transplant Procedures (2012-2017)
Figure 2.13 Number of Transplant Procedures (2012-2017)
Figure 2.14 Number of Transplant Procedures (2012-2016)
Figure 2.15 Number of Transplant Procedures (2012-2017)
Figure 4.1 Global Transplant Market Segmentation by Product
Figure 5.1 Global Transplant Market Segmentation by Application
Figure 5.2 Global Tissue Transplant Market Segmentation by Type
Figure 5.3 Global Organ Transplant Market Segmentation by Type Revenue (%), 2017-2029
Figure 7.1 Transplant Market Landscape
Figure 8.1 Global Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.2 Global Transplant Market by Regional Breakdown:
Figure 8.3 Global Transplant Market by Regional Market Share (%), 2017
Figure 8.4 Global Transplant Market by Regional Market Share (%), 2023
Figure 8.5 Global Transplant Market by Regional Market Share (%), 2029
Figure 8.6 North America Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.7 North America Transplant Market by Regional Breakdown: Revenue (%), 2017 & 2029
Figure 8.8 North America Transplant Market by Product (% Share): 2017, 2023, & 2029
Figure 8.9 North America Transplant Market by Application (% Share): 2017, 2023, & 2029
Figure 8.10 North America Transplant Market by End-User (% Share): 2017, 2023, & 2029
Figure 8.11 Europe Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.12 Europe Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
Figure 8.13 Europe Transplant Market by Product (% Share), 2017, 2023, & 2029
Figure 8.14 Europe Transplant Market by Application (% Share), 2017, 2023, & 2029
Figure 8.15 Europe Transplant Market by End-User (% Share), 2017, 2023, & 2029
Figure 8.16 Asia-Pacific Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.17 Asia-Pacific Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
Figure 8.18 Asia Pacific Transplant Market by Product (% Share): 2017, 2023, & 2029
Figure 8.19 Asia-Pacific Transplant Market by Application (% Share): 2017, 2023, & 2029
Figure 8.20 Asia-Pacific Transplant Market by End-User (% Share): 2017, 2023, & 2029
Figure 8.21 RoW Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.22 RoW Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
Figure 8.23 RoW Transplant Market by Product (% Share): 2017, 2023, & 2029
Figure 8.24 RoW Transplant Market by Application (% Share): 2017, 2023, & 2029
Figure 8.25 RoW Transplant Market by End-User: (% Share), 2017, 2023, & 2029
Figure 9.1 Zimmer Biomet: SWOT Analysis
Figure 9.2 AbbVie Inc.: SWOT Analysis
Figure 9.3 Teva Pharmaceuticals: SWOT Analysis
Figure 9.4 Novartis AG: SWOT Analysis
Figure 9.5 Medtronic: SWOT Analysis
Figure 9.6 Arthrex: SWOT Analysis
Figure 9.7 Stryker: SWOT Analysis
Figure 9.8 Veloxis Pharmaceuticals: SWOT Analysis
Figure 11.1 Global Transplant Market: Market Opportunity by Region (% share) 2017 and 2029
Figure 11.2 Global Transplant Market: Market Opportunity by Application (% share) 2017 and 2029
21st Century Medicine
Abbott Laboratories
AbbVie, Inc.
Accord Healthcare GmbH
Accord Healthcare Ltd.
AllCells LLC
Allergan
AlloSource, Inc.
AmerisourceBergen Corporation
Apaxis Medical, Inc.
Arthrex, Inc.
Astellas Pharma, Inc.
AveXis, Inc.
Avita Medical
B.Braun Melsungen
Bard Peripheral Vascular Inc.
Baxter International
BioLife Solutions
BioLifeSolutions, Inc
BioTime
Boston Scientific Corp.
Bridge to Life
Bristol-Myers Squibb
Calon Cardio
CardiacAssist Inc.
Cardinal Health, Inc.
Cayenne Medical Inc.
Chiesi Farmaceutici S.p.A.
Claris Lifesciences
Colibri Heart Valve, LLC.
Coloplast
CONMED
Convatec Inc
Cook Medical
Cryolife
Danaher Corporation
Dentsply International
DePuy Synthes
Dr. F. Köhler Chemie
Edwards Lifesciences Corp.
Envarsus XR
Exactech
F. Hoffmann-La Roche Ltd.
Forticell Bioscience
Genzyme
Genzyme Corporation
Getinge Group
GlaxoSmithKline Plc.
Globus Medical, Inc.
Harvard Apparatus Regenerative Technologies
HeartWare
HeartWare International Inc.
Hill-Rom Holdings, Inc.
Integra Lifescience
Johnson & Johnson
Junken Medical Co., Ltd.
Karl Storz GmbH & Co.
Kiadis Pharma
Koninklijke Philips N.V.
LeMagitre Vascular Inc.
Lifeblood Medical
Lifeline Scientific
Lonza Group Ltd.
McKesson Corporation
Medrotonic
Merck Millipore
Mylan Laboratories, Inc.
Novartis AG
Nuvasive, Inc.
Olympus Optical Co. Ltd.
Optum Inc.
Organogenesis, Inc.
Organovo
Orthofix Holdings, Inc.
Penumbra, Inc.
Pfizer, Inc.
Preservation Solutions, Inc.
Sanofi
Sanofi; Pfizer, Inc.
Sanofi-Aventis LLC.
Smith & Nephew plc
Specmed Medical
STEMCELL Technologies
STERIS plc
Stratatech Corp.
Straumann Holding AG.
Stryker
SynCardia Systems, LLC
Terumo Cardiovascular
Terumo Corporation
Terumo Medical Corp.
Teva Pharmaceuticals
Thoratec Corporation.
Tissue Regenix Group PLC
TTK Healthcare Ltd
Veloxis Pharmaceuticals
Wright Medical Group N.V.
Zimmer Biomet
Zoll Medical Corporation
List of Organizations Mentioned in the Report
American Academy of Orthopaedic Surgeons
American Association of Tissue Banks (AATB)
Centers for Disease Control and Prevention
European Commission
Eurotransplant International Foundation (ET)
FDA
Groote Schur Hospital
Harvard University
Health Care Finance Administration (HCFA)
Hospital Universitari Vall d'Hebron
Japan Organ Transplant Network
Japanese Ministry of Health, Labour and Welfare
Johns Hopkins University School of Medicine
Ministry of Health (MoH)
National Central Cancer Registry of China
National Development and Reform Commission (NDRC)
Network of Organ Sharing (UNOS)
NHS Blood and Transplant
Stanford Medical Center
United States Department of Defense
United States Department of Veterans Affairs
University of Colorado
University of Mississippi
WHO
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
